Recharge Capital Announces $200M Women’s Healthcare Investment Holdings Co. With a Novel Structure

The holding company is backed by top investors including Peter Thiel and will focus on driving innovation and integration in the fertility value chain, including IVF, menstrual wellness and women's disease prevention

NEW YORK--(BUSINESS WIRE)--Recharge Capital, the leading thematic-first private investment firm, today announced the successful closure of the first tranche of its Women’s Healthcare Investment Vehicle, backed with funding from esteemed investors including Peter Thiel of Thiel Capital, The Olayan Family of the Olayan Group, Blue Lion Group, The Al Rashid Family of the Salmira Investment Fund, Shamrock Holdings of the Disney Family, the Ozmen Family of the Sierra Nevada Corporation, Ian Osborne of Hedosophia, Frank Liu of Texas-based Lovett, and other renowned investment groups.

This first tranche closure takes a novel private equity structure to align investors with a milestone-driven deployment schedule rather than the typical capital call model, and presents clear multi-year execution plans. The vehicle will serve to optimize thematic-based investments and set the stage for transformative growth in the women’s healthcare industry.

The raised funds will be strategically deployed to invest, roll up, and create an end-to-end ecosystem within the women's fertility value chain across Southeast Asia, Latin America, Europe, and the Middle East. A primary focus will be placed on international fertility medical tourism, menstrual wellness, and women's disease prevention. Recharge Capital aims to transform the sector by creating full-scale integration of disruptive technologies, diagnostic solutions, and seamless patient experiences through digital platforms and local clinic chains.

"Women's healthcare, within our thematic-first investment framework, holds tremendous potential for both substantial growth and positive societal impact, as it addresses the needs of half of the global population," said Lorin Gu, Founding Partner of Recharge Capital. "With the support of our strategic partners and a team of expert investors, we are thrilled to spearhead global women's healthcare and fertility through an innovative investment and operating structure that fosters effective value creation.”

The Sector Integration Vehicle, a brainchild of Recharge Capital, employs a milestone-driven approach, ensuring transparency for investors and clear execution plans. The holding company currently holds assets from Singapore, Southeast Asia, Mexico, U.S., Israel, and Taiwan.

The women's healthcare sector plays a critical role in tackling the pressing fertility challenges faced by our society today. This newly established holding company will address existing bottlenecks in women's healthcare and fertility services across multiple vital international markets. By efficiently integrating and scaling new technology and diagnostic solutions, the company aims to provide enhanced care to patients worldwide.

As an active investment vehicle in health technology and service providers, Recharge Capital remains committed to driving innovation and accessibility in fertility and women's healthcare through strategic partnerships with cutting-edge innovators. In addition to women's healthcare, Recharge Capital is actively investing in sectors such as fintech democratization, digital assets, and semiconductor enablement.

About Recharge Capital:

Recharge Capital is a leading thematic-first private investment firm focused on driving innovation and impact across various sectors. With a strong emphasis on women's healthcare and fertility, the firm leverages its expertise and strategic partnerships to invest, scale, and optimize transformative businesses. Recharge Capital operates from its offices in New York and Singapore, serving as a catalyst for positive change in the global investment landscape. For further information about Recharge Capital and its women's healthcare and fertility initiatives, please visit our website at www.rechargecapital.com or contact our press office at [e-mail].